Steidl, C., Shah, S. P., Woolcock, B. W., Rui, L., Kawahara, M., Farinha, P., . . . Gascoyne, R. D. (2011). MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
Chicago Style CitationSteidl, Christian, et al. MHC Class II Transactivator CIITA Is a Recurrent Gene Fusion Partner in Lymphoid Cancers. 2011.
Cita MLASteidl, Christian, et al. MHC Class II Transactivator CIITA Is a Recurrent Gene Fusion Partner in Lymphoid Cancers. 2011.
Atenció: Aquestes cites poden no estar 100% correctes.